WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹173 Cr | ₹109 Cr | ₹64 Cr | ₹67 Cr | ₹160 Cr |
What is the latest Total Debt ratio of WANBURY ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹173 Cr |
| Mar2024 | ₹109 Cr |
| Mar2023 | ₹64 Cr |
| Mar2022 | ₹67 Cr |
| Mar2021 | ₹160 Cr |
How is Total Debt of WANBURY Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹173 Cr | 58.53 | |
| Mar2024 | ₹109 Cr | 70.37 | |
| Mar2023 | ₹64 Cr | -4.30 | |
| Mar2022 | ₹67 Cr | -58.22 | |
| Mar2021 | ₹160 Cr | - | |
Compare Total Debt of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹943.0 Cr | -1.1% | 3.8% | 1.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -1.9% | -7.3% | -2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,939.0 Cr | 1.8% | 3.3% | 9.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,109.0 Cr | -0.5% | -4% | 29.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,578.0 Cr | 0.2% | -4.9% | 6.6% | Stock Analytics | |
| CIPLA | ₹99,761.1 Cr | 0.5% | -3.8% | -17% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | -1.1% |
3.8% |
1.7% |
| SENSEX | 0.5% |
3.2% |
2.3% |
You may also like the below Video Courses